AFMD News and Press, Affimed N.V. From 01/11/21

Heidelberg, Germany, January 11, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that its Chief Executive Officer, Dr. Adi Hoess, will present at the 39th Annual J...

€10 million available at closing and up to €15 million available upon achievement of certain milestones Heidelberg, Germany, January 11, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their inna...

Affimed N.V. (AFMD) reports cash and cash equivalents of ~€147M as of Dec. 31st, that provides cash runway into the first half of 2023.Clinical stage program, AFM13 (CD30/CD16A ICE), a Phase 2 registration-directed study of AFM13 as monotherapy in relapsed or refractory patients w...

Continued progress for AFM13 and AFM24 clinical studies Strengthened cash position provides anticipated runway into the first half of 2023 Heidelberg, Germany, January 7, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving ...

Affimed continues to amass a stockpile of partnerships and collaborations that amplifies the risk-reward profile for an AFMD investment. As a result, I am looking to accumulate a larger position. I provide a brief overview of the company's current partnerships and will discuss why I b...

AFM13 monotherapy was well tolerated and reached an Objective Response Rate of 42 percent among heavily pretreated patients with R/R CD30-positive lymphoma with cutaneous presentation Immunological analyses revealed that innate cell engagers modulate NK and T cell populations in...

Eastman Kodak (KODK) +76%. as DFC says no laws were broken.Greenland Technologies Holding (GTEC) +60% on launching 'electric industrial vehicle market' divisionObalon Therapeutics (OBLN) +52%.Oncternal Therapeutics (ONCT) +27% on presentation of interim phase 1/2 data...

Why Should You Pay Attention to These Penny Stocks Right Now? When it comes to penny stocks , finding the biggest gainers of the day can be a good step in the right direction. This allows investors to see what type of momentum a penny stock has. In addition, it can help to identify ...

The phase 1b study showed a complete response (CR) rate of 46% (objective response rate [ORR] of 88%) at the recommended dose level in patients with relapsed/refractory (R/R) Hodgkin lymphoma, whereas in a separate study MSD’s KEYTRUDA demonstrated an ORR of 69% and a CR of...

Affimed N.V. (AFMD) Q3 2020 Earnings Conference Call November 10, 2020 08:30 ET Company Participants Alexander Fudukidis - Head, Investor Relations Adi Hoess - Chief Executive Officer Andreas Harstrick - Chief Medical Officer Denise Mueller - Chief Business Officer Wolfgang Fischer - Chief Op...